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P U B L I S H E D B Y E L S E V I E R I N C .iagnosis of Patent
oramen Ovale
e read with great interest the improved echocardiographic
iagnostic protocol for patent foramen ovale (PFO) by Rana et
l. (1). We wish to highlight some relevant issues.
Demonstrating the presence of PFO does not establish its
tiopathogenic role in systemic embolization. A small-sized
FO may be associated with higher “functional potential” and
lay a more important etiological role compared with its
orphology. Transesophageal echocardiography (TEE) is
onsidered the gold standard for diagnosing PFO, because it
rovides anatomical details and can occasionally visualize the
ravel of a thrombus in real time. However, TEE requires an
xpert echocardiographer, is poorly tolerated by patients, and
he Valsalva maneuver (VM) is often impaired by sedation and
he endoscope in the throat. Although these limitations do not
nterfere with diagnostic capability, they may affect the func-
ional grading of PFO. Some of these limitations may be
vercome with transcranial Doppler (TCD). TCD is a reliable
echnique with accuracy parameters comparable with those of
EE (2). Because TCD does not require sedation, an effective
M can be performed by most subjects.
Considerable variations exist in the timing of the VM
uring the diagnostic testing for PFO. Although some studies
erformed the VM simultaneously with the contrast injection
3), others initiated it after 3 to 5 s (2). Substantial hemody-
amic changes occur during the “strain phase” of the VM
amplifying the interatrial left-to-right pressure gradient and
ounteracting right-to-left shunting) as well as the “release
hase” (reversing the pressure gradient with a sudden increase
n venous return and right atrial pressure facilitating right-to-
eft shunt). Importantly, considerable reduction and even
omplete stoppage of flow occurs in proximal veins during the
M. Thus, injecting contrast during the VM into a proximal
ein seems counterproductive, because the high venous pres-
ure might destroy some microbubbles. Furthermore, micro-
ubbles created by vigorous shaking of the contrast mixture
ave short life and may not reach the heart in sufficient
umbers, diminishing the functional grading of PFO.
Body position during the diagnosis of PFO needs special
onsideration. Air bubbles, being lighter, tend to “move up”
ecause of buoyancy. Thus, patients’ left lateral position during
chocardiography is not conducive for the travel of micro-ubbles (from the higher right atrium into the lower left
trium). We observed that the “functional grade” of PFO
aries with body position, and a larger number of microbubbles
re detected in the sitting position (4). Additionally, the sitting
osition may promote opening of the shunt flap during the
M, helping more microbubbles cross the shunt. Changing
ody positioning from supine to sitting upright substantially
ncreased the microbubble count (from a median of 20 in the
upine position to 72 in the sitting position) in 42% of our
tudy population (4). Establishing the functional grade of a
FO is important because it provides useful information about
he likelihood of prevalent ischemic stroke as well as the risk
or recurrent events (5).
We reiterate that the simple detection of a PFO does not
elineate its true etiopathogenic role. Establishing the “func-
ional status” of a PFO is essential for planning definitive
reatment. We propose that TCD, performed in various body
ositions, should be used for screening and establishing the
unctional grade of a right-to-left shunt, and echocardiography
ay be performed in selected patients to evaluate the mor-
hological characteristics of PFO.
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